Claire L Harris

Claire L Harris

Newcastle University

H-index: 65

Europe-United Kingdom

About Claire L Harris

Claire L Harris, With an exceptional h-index of 65 and a recent h-index of 34 (since 2020), a distinguished researcher at Newcastle University, specializes in the field of Innate immunity, Drug discovery, Complement, Therapeutics, Biomarkers.

His recent articles reflect a diverse array of research interests and contributions to the field:

Identification and quantification of chain-pairing variants or mispaired species of asymmetric monovalent bispecific IgG1 monoclonal antibody format using reverse-phase …

Quiescence enables unrestricted cell fate in naive embryonic stem cells

Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID‐19

Magnesium and Fracture Risk in the General Population and Patients Receiving Dialysis: A Narrative Review

The case for complement component 5 as a target in neurodegenerative disease

The complement alternative pathway in health and disease—activation or amplification?

Gene targeting as a therapeutic avenue in diseases mediated by the complement alternative pathway

Interplay of heavy chain introns influences efficient transcript splicing and affects product quality of recombinant biotherapeutic antibodies from CHO cells

Claire L Harris Information

University

Position

___

Citations(all)

22358

Citations(since 2020)

9911

Cited By

8139

hIndex(all)

65

hIndex(since 2020)

34

i10Index(all)

140

i10Index(since 2020)

104

Email

University Profile Page

Google Scholar

Claire L Harris Skills & Research Interests

Innate immunity

Drug discovery

Complement

Therapeutics

Biomarkers

Top articles of Claire L Harris

Identification and quantification of chain-pairing variants or mispaired species of asymmetric monovalent bispecific IgG1 monoclonal antibody format using reverse-phase …

Journal of Chromatography B

2024/4/15

Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID‐19

Immunology

2023/3

The case for complement component 5 as a target in neurodegenerative disease

2023/2/1

Claire L Harris
Claire L Harris

H-Index: 32

The complement alternative pathway in health and disease—activation or amplification?

2023/1

Claire L Harris
Claire L Harris

H-Index: 32

Gene targeting as a therapeutic avenue in diseases mediated by the complement alternative pathway

2023/1

Scott Ellis
Scott Ellis

H-Index: 11

Claire L Harris
Claire L Harris

H-Index: 32

Interplay of heavy chain introns influences efficient transcript splicing and affects product quality of recombinant biotherapeutic antibodies from CHO cells

Mabs

2023/12/31

Gridded glyphmaps for supporting spatial COVID-19 modelling

2023/10/21

Variability in Reporting eGFR at Dialysis Initiation in Canada: A Research Letter

Canadian Journal of Kidney Health and Disease

2023/9

14 Functional activity of CD35 (Complement Receptor 1; CR1) in the conversion of complement fragment iC3b to C3dg

Immunobiology

2023/9/1

CHO synthetic promoters improve expression and product quality of biotherapeutic proteins

Biotechnology Progress

2023/9

XXIX International Complement Workshop Newcastle 2023.

Immunobiology

2023/8/10

Methods of producing recombinant complement proteins, vectors and therapeutic uses thereof

2023/7/6

Pre-eclampsia is associated with complement pathway activation in the maternal and fetal circulation, and placental tissue

Pregnancy Hypertension

2023/6/1

Long Xie
Long Xie

H-Index: 13

Edwin Wong
Edwin Wong

H-Index: 3

Claire L Harris
Claire L Harris

H-Index: 32

Bruch’s membrane: a key consideration with complement-based therapies for age-related macular degeneration

2023/4/14

A novel method for real-time analysis of the complement C3b:FH:FI complex reveals dominant negative CFI variants in age-related macular degeneration

Frontiers in Immunology

2022/12/28

Monoclonal antibody sequence variants disguised as fragments: identification, characterization, and their removal by purification process optimization

Journal of Pharmaceutical Sciences

2022/11/1

Strong phylogenetic signals in global plant bioclimatic envelopes

Global Ecology and Biogeography

2022/11

Correction to: ‘Visualization for epidemiological modelling: challenges, solutions, reflections and recommendations’ (2022) by Dykes et al.

Philosophical Transactions of the Royal Society A

2022/10/31

See List of Professors in Claire L Harris University(Newcastle University)